{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:13:51Z","timestamp":1746677631917,"version":"3.40.5"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\nBackground<\/jats:title>\nPeople living with human immunodeficiency virus (HIV) are more likely to be infected with human papillomavirus (HPV), which can lead to anal and oropharyngeal cancer in males, increasing the complexity of the disease.<\/jats:p>\n<\/jats:sec>\n\nObjective<\/jats:title>\nThe aim of this study is to learn more about epidemiological data and factors influencing anal and oropharyngeal HPV infections in males with HIV through a systematic literature review in order to provide evidence for future interventions.<\/jats:p>\n<\/jats:sec>\n\nMethods<\/jats:title>\nThe PubMed, Embase, Web of Science, Cochrane Library, PsycINFO, and ClinicalTrials.gov databases will be searched from build to June 2024. Two researchers will independently carry out study selection, data extraction and risk of bias assessment. STATA 16.0 will be used to conduct meta-analysis. The estimated pooled prevalence of anal and oropharyngeal HPV (any HPV, high-risk HPV, low-risk HPV, type-specific HPV, and multiple HPV) in males living with HIV will be presented as percentage prevalence (p * 100%) with corresponding 95% confidence intervals (CI) by DerSimonian-Laird random-effect meta-analyses. Subgroup analysis will carried out by geographic region, income level, race, age, publication year, HPV genotyping, and risk factors (e.g., sexual behavior patterns). Risk factors and interventions-related dichotomous variables or continuous variables will be summarized as odds ratios (OR) and standardized mean differences, and reported through forest plots. The OR (greater than 1) shows an association (correlated). Heterogeneity will be assessed using the I2<\/jats:sup>. Funnel plots, Begg and Egger tests will be applied to detect potential publication bias.<\/jats:p>\n<\/jats:sec>\n\nPROSPERO registration number<\/jats:title>\nCRD42024579641.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0320899","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T20:09:02Z","timestamp":1746648542000},"page":"e0320899","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The epidemiology and risk factors of anal and oropharyngeal human papillomavirus (HPV) in males living with human immunodeficiency virus (HIV): A protocol for systematic review and meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-5209","authenticated-orcid":true,"given":"Mengni","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunlin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"5","key":"pone.0320899.ref001","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2462","article-title":"A systematic review on the molecular and clinical association between Human Papillomavirus and Human Immunodeficiency Virus co-infection in Head, Neck and Oral squamous cell carcinoma","volume":"33","author":"S Chakraborty","year":"2023","journal-title":"Rev Med Virol"},{"issue":"3","key":"pone.0320899.ref002","doi-asserted-by":"crossref","first-page":"2281700","DOI":"10.1080\/21645515.2023.2281700","article-title":"Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16-26 years in Chongqing, China","volume":"19","author":"Y-Y Zhang","year":"2023","journal-title":"Hum Vaccin Immunther"},{"issue":"10","key":"pone.0320899.ref003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/v9100267","article-title":"Natural History of HPV Infection across the Lifespan: Role of Viral Latency","volume":"9","author":"PE Gravitt","year":"2017","journal-title":"Viruses"},{"issue":"2","key":"pone.0320899.ref004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40618-023-02192-3","article-title":"HPV-related diseases in male patients: an underestimated conundrum","volume":"47","author":"A Garolla","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"pone.0320899.ref005","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10020256","article-title":"Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data: A Systematic Review","volume":"10","author":"M Kurosawa","year":"2022","journal-title":"Vaccines"},{"issue":"6","key":"pone.0320899.ref006","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/vaccines11061067","article-title":"Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV","volume":"11","author":"C Losada","year":"2023","journal-title":"Vaccines"},{"key":"pone.0320899.ref007","doi-asserted-by":"crossref","first-page":"101585","DOI":"10.1016\/j.eclinm.2022.101585","article-title":"Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis","volume":"52","author":"L Staadegaard","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"5","key":"pone.0320899.ref008","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/microorganisms10051047","article-title":"Update on the Epidemiological Features and Clinical Implications of Human Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV) Coinfection","volume":"10","author":"A P\u00e9rez-Gonz\u00e1lez","year":"2022","journal-title":"Microorganisms"},{"issue":"4","key":"pone.0320899.ref009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/aid.2022.0128","article-title":"Risk Factors for Human Papillomavirus-Associated Cancers Among People Living with HIV in Washington, District of Columbia","volume":"39","author":"AV Waters","year":"2023","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"pone.0320899.ref010","doi-asserted-by":"crossref","first-page":"2334001","DOI":"10.1080\/21645515.2024.2334001","article-title":"Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)","volume":"20","author":"V Fernandez-Alonso","year":"2024","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"8","key":"pone.0320899.ref011","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015","volume":"112","author":"AA Deshmukh","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"key":"pone.0320899.ref012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pvr.2018.05.001","article-title":"A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men","volume":"6","author":"GB Ellsworth","year":"2018","journal-title":"Papillomavirus Res"},{"issue":"2","key":"pone.0320899.ref013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnci\/djad214","article-title":"Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019","volume":"116","author":"SV Gopalani","year":"2024","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"pone.0320899.ref014","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/LGT.0000000000000859","article-title":"Trends in Cervical and Anal Cancer Incidence and Mortality in the United States","volume":"29","author":"TR McKinnish","year":"2025","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"pone.0320899.ref015","first-page":"180","article-title":"Screening for HPV-Related Oropharyngeal Cancer in Gay and Bisexual Men: Acceptability and Predicting Possible Use of \u201cOral Selfies\u201d by Smartphone as a Secondary Prevention Approach","volume":"2","author":"MW Ross","year":"2023","journal-title":"Venereology (Basel, Switzerland)"},{"issue":"6","key":"pone.0320899.ref016","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jso.26687","article-title":"Epidemiology and incidence of HPV-related cancers of the head and neck","volume":"124","author":"BR Roman","year":"2021","journal-title":"J Surg Oncol"},{"issue":"11","key":"pone.0320899.ref017","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70062","article-title":"Oropharyngeal cancer: Lack of human papillomavirus awareness and economic burden in the United States","volume":"14","author":"M Lechner","year":"2024","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"pone.0320899.ref018","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13027-024-00616-0","article-title":"The epidemic of human papillomavirus virus-related oropharyngeal cancer: current controversies and future questions","volume":"19","author":"AM Chen","year":"2024","journal-title":"Infectious agents and cancer"},{"issue":"4","key":"pone.0320899.ref019","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/QAI.0000000000002891","article-title":"Effects of Sex, Existing Antibodies, and HIV-1-Related and Other Baseline Factors on Antibody Responses to Quadrivalent HPV Vaccine in Persons With HIV","volume":"89","author":"M Kang","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"pone.0320899.ref020","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-14-2843","article-title":"NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men","volume":"75","author":"AK Chaturvedi","year":"2015","journal-title":"Cancer research"},{"issue":"7","key":"pone.0320899.ref021","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010","volume":"307","author":"ML Gillison","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"pone.0320899.ref022","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41598-021-03913-5","article-title":"Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV","volume":"12","author":"MG Don\u00e0","year":"2022","journal-title":"Sci Rep"},{"issue":"11","key":"pone.0320899.ref023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052176","article-title":"Anal human papillomavirus infection among men who have sex with men and transgender women living with and without HIV in Pakistan: findings from a cross-sectional study","volume":"11","author":"M Ejaz","year":"2021","journal-title":"BMJ Open"},{"issue":"3","key":"pone.0320899.ref024","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ijc.34269","article-title":"Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis","volume":"152","author":"AA Deshmukh","year":"2023","journal-title":"Int J Cancer"},{"issue":"12","key":"pone.0320899.ref025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/09564624221123869","article-title":"Prevalence of oral and anal human papillomavirus infection in Czech predominantly HIV-positive men having sex with men - data from a previously unreported population","volume":"33","author":"J Nemcova","year":"2022","journal-title":"Int J STD AIDS"},{"issue":"9","key":"pone.0320899.ref026","article-title":"Anal and oropharyngeal HPV distribution in HIV-negative multipartner MSM using self-sampling kits for HIV and sexually transmitted infection screening","volume":"95","author":"J-L Pr\u00e9tet","year":"2023","journal-title":"J Med Virol"},{"issue":"7","key":"pone.0320899.ref027","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/hiv.13602","article-title":"Screening and prevention of HPV-related anogenital cancers in women living with HIV in Europe: Results from a systematic review","volume":"25","author":"D Krankowska","year":"2024","journal-title":"HIV Med"},{"issue":"9","key":"pone.0320899.ref028","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s10096-024-04887-8","article-title":"Oral HPV infection clearance and acquisition after nonavalent vaccination in men who have sex with men and transgender women: a prospective analysis","volume":"43","author":"R Rossotti","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"pone.0320899.ref029","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy274","article-title":"A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298","volume":"67","author":"TJ Wilkin","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pone.0320899.ref030","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.31557\/APJCP.2021.22.9.2729","article-title":"Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis","volume":"22","author":"JO Okoye","year":"2021","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"1","key":"pone.0320899.ref031","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1038\/s41598-017-07506-z","article-title":"HPV prevalence in the foreskins of asymptomatic healthy infants and children: Systematic review and meta-analysis","volume":"7","author":"B Lee","year":"2017","journal-title":"Scientific Reports"},{"issue":"10","key":"pone.0320899.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025493","article-title":"Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis","volume":"6","author":"A Ciapponi","year":"2011","journal-title":"PLoS One"},{"key":"pone.0320899.ref033","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1080\/21645515.2019.1600985","article-title":"HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection","volume":"15","author":"MR Timbang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"pone.0320899.ref034","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.3390\/ijms25063437","article-title":"Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal Dysplasia and Cancer Screening-A Systematic Review and Meta-Analysis","volume":"25","author":"S Tous","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0320899.ref035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12981-025-00709-9","article-title":"Challenges in the implementation of a high-resolution anoscopy clinic for people with HIV in an oncologic center in Mexico City","volume":"22","author":"P Volkow","year":"2025","journal-title":"AIDS Res Ther"},{"issue":"6","key":"pone.0320899.ref036","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002568","article-title":"Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial","volume":"9","author":"RL Ferris","year":"2021","journal-title":"Journal for Immunotherapy of Cancer"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T20:09:08Z","timestamp":1746648548000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320899"}},"subtitle":[],"editor":[{"given":"Hope","family":"Onohuean","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320899","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}